To find out if CADM1 expression did in fact inhibit squamous cell carcinoma progression, they studied its effects on the growth and migration of the CADM1-null squamous cell carcinoma cell line A431. Some of the cells were treated with doxycycline. The CADM1 transduced cells that were treated with doxycycline restored CADM1 gene and protein expression to normal levels. The CADM1 transduced cells that weren’t treated with doxycycline could not be distinguished from the squamous cell carcinoma controls. The researchers also used mice in their study. They injected the mice with either control or CADM1 expressing A431 cells. Reduced squamous cell carcinoma growth was seen in CADM1 expressing tumors compared to controls, and also significantly fewer squamous cell carcinoma metastases were seen in A431-CADM1 tumor bearing mice compared to those seen in untransduced squamous cell carcinoma controls. The results showed that CADM1 inhibits squamous cell carcinoma progression by reducing cell proliferation and
To find out if CADM1 expression did in fact inhibit squamous cell carcinoma progression, they studied its effects on the growth and migration of the CADM1-null squamous cell carcinoma cell line A431. Some of the cells were treated with doxycycline. The CADM1 transduced cells that were treated with doxycycline restored CADM1 gene and protein expression to normal levels. The CADM1 transduced cells that weren’t treated with doxycycline could not be distinguished from the squamous cell carcinoma controls. The researchers also used mice in their study. They injected the mice with either control or CADM1 expressing A431 cells. Reduced squamous cell carcinoma growth was seen in CADM1 expressing tumors compared to controls, and also significantly fewer squamous cell carcinoma metastases were seen in A431-CADM1 tumor bearing mice compared to those seen in untransduced squamous cell carcinoma controls. The results showed that CADM1 inhibits squamous cell carcinoma progression by reducing cell proliferation and